Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.


CSE:BUX - Post by User

Post by geodcanon Jan 07, 2023 12:28am
329 Views
Post# 35208394

according to the insider banner

according to the insider bannerG Huang seems to be picking up a thousand or two shares to keep this alive and looking active, at least from a trading view.

Not sure if he has marketmaker status but most of the trading is him, I believe.
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities